Protective effects of probucol treatment on pancreatic beta-cell function of SZ-induced diabetic APA hamsters.
To clarify whether oxidative stress is involved in the pathogenesis of islet lesions of diabetic animals, the effects of probucol (PB), an antioxidant and anti-hyperlipidemia agent, on the islets in streptozotocin (SZ)-induced diabetic APA hamsters in the acute and chronic phases of diabetes were examined. The control (CB group) and diabetic (SZ group) hamsters were treated with PB (1% in the diet) for 4 weeks from several days after SZ injection as the acute diabetic group, or 8 weeks from 6 weeks after SZ injection as the chronic diabetic group. Glucose tolerance test revealed that PB treatment decreased the high serum glucose level after glucose injection in the diabetic APA hamsters in the acute diabetic phase. Immunohistochemistry revealed that PB treatment significantly increased the percentage of the insulin positive area in the diabetic hamsters pancreata in both the acute and chronic phases. In addition, 4-hydroxy-2-nonenal (4HNE; an oxidative stress marker) positive cells were slightly reduced by PB treatment in the acute diabetic phase. Double-immunostaining for insulin and PCNA (proliferating cell nuclear antigen) revealed that elevation of the percentage of insulin and PCNA double-positive cells against insulin-positive cells was seen in the islets of PB-treated diabetic hamsters, but the difference was not significant compared with untreated diabetic hamsters (p = 0.07). In semi-quantitative RT-PCR, the expression of two genes, Reg (Regenerating gene) and INGAP (islet neogenesis associated protein), in the diabetic APA hamsters was significantly increased compared to the control groups in both diabetic phases. PB treatment significantly reduced Reg expression in the chronic diabetic phase. These data suggest that PB treatment in SZ-injected diabetic hamsters partially restored beta-cell function through acting as an antioxidant and induced higher expression of Reg and INGAP genes in the pancreas of hamsters.
Takatori
Atsushi
A
Department of Biomedical Science, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Ohta
Etsuko
E
Inenaga
Toshiaki
T
Horiuchi
Keiko
K
Ishii
Yoshiyuki
Y
Itagaki
Shin-ichi
S
Kyuwa
Shigeru
S
Yoshikawa
Yasuhiro
Y
D000447:Aldehydes / Q000032:analysis; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D015415:Biomarkers / Q000032:analysis; D006224:Cricetinae; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology / Q000517:prevention & control*; D007515:Islets of Langerhans / Q000187:drug effects*; D008297:Male; D008647:Mesocricetus; D018384:Oxidative Stress; D000073718:Pancreatitis-Associated Proteins; D011341:Probucol / Q000494:pharmacology*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D013311:Streptozocin
D000447:Aldehydes; D000924:Anticholesteremic Agents; D000975:Antioxidants; D015415:Biomarkers; D000073718:Pancreatitis-Associated Proteins; D018809:Proliferating Cell Nuclear Antigen; C000612141:REG3A protein, human; D013311:Streptozocin; C027576:4-hydroxy-2-nonenal; D011341:Probucol